Inquire About a Product| Product: | Mometasone furoate-d3 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | D3559 | ||||||||
| Unlabeled CAS Number: | 83919-23-7 | ||||||||
| Pricing: |
|
||||||||
| Formula: | C27H27D3Cl2O6 | ||||||||
| Enrichment: | 98%D | ||||||||
| Molecular Weight: | 524.45 | ||||||||
| Structure: |
|
||||||||
| Appearance: | White solid | ||||||||
| Category: | Labeled Reference Standards | ||||||||
| Stability: | Stable under recommended storage conditions. | ||||||||
| Storage: |
Keep tightly closed |
||||||||
| Transportation: |
Non-hazardous for transport |
||||||||
| Literature References: |
Zia R Tayab, Tom C Fardon, Daniel K C Lee, Kay Haggart, Lesley C McFarlane, Brian J Lipworth, and Günther Hochhaus, Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate. Br J Clin Pharmacol, 2007, 64 (5): 698–705.; Tan RA, Corren J., Mometasone furoate in the management of asthma: a review. Ther Clin Risk Manag, 2008, 4 (6): 1201–8. |
||||||||
| MSDS: | |||||||||
| Applications: | A labeled glucocorticosteroid used to reduce inflammation of the skin or in the airways. Used to treat inflammatory skin disorders, allergic rhinitis, and asthma. |